ResMed Inc., a leader in the medical technology sector, is headquartered in the United States and operates extensively across North America, Europe, and Asia-Pacific. Founded in 1989, ResMed has established itself in the precision and optical instruments industry, focusing primarily on innovative solutions for sleep apnoea and chronic obstructive pulmonary disease (COPD).
The company is renowned for its advanced cloud-connected devices, including CPAP machines and digital health solutions, which enhance patient care and streamline clinical workflows. ResMed's commitment to research and development has positioned it as a market leader, with significant achievements in improving patient outcomes and driving industry standards. With a strong emphasis on technology integration, ResMed continues to redefine the landscape of respiratory care and sleep medicine.
+24 vs industry average
Resmed’s score of 52 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Resmed?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has below-average carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Resmed's reported carbon emissions
ResMed, a leading medical technology company, has reported its greenhouse gas emissions and climate commitments.
Emissions Data:
- 2025: Scope 1 emissions were approximately 3,957,000 kg CO2e, and Scope 2 emissions were approximately 23,573,000 kg CO2e. The combined Scope 1 and 2 emissions totalled approximately 27,530,000 kg CO2e.
- 2024: Scope 1 emissions were approximately 4,236,000 kg CO2e, and Scope 2 emissions were approximately 24,422,000 kg CO2e. The combined Scope 1 and 2 emissions totalled approximately 28,658,000 kg CO2e.
- 2023: Scope 1 emissions were approximately 4,453,000 kg CO2e, and Scope 2 emissions were approximately 23,939,000 kg CO2e. The combined Scope 1 and 2 emissions totalled approximately 28,391,000 kg CO2e.
- 2022: Scope 1 emissions were approximately 3,743,000 kg CO2e, and Scope 2 emissions were approximately 21,317,000 kg CO2e. The combined Scope 1 and 2 emissions totalled approximately 25,059,000 kg CO2e.
- 2021: Scope 1 emissions were approximately 2,418,000 kg CO2e, and Scope 2 emissions were approximately 22,246,000 kg CO2e. The total Scope 1 and 2 emissions were approximately 23,028,000 kg CO2e.
- 2020: The total Scope 1 and 2 emissions were approximately 22,171,000 kg CO2e.
- 2019: The total Scope 1 and 2 emissions were approximately 19,193,000 kg CO2e.
- 2018: The total Scope 1 and 2 emissions were approximately 19,353,000 kg CO2e.
- 2017: The total Scope 1 and 2 emissions were approximately 22,290,000 kg CO2e.
ResMed has not yet disclosed its Scope 3 emissions data.
Climate Commitments and Targets:
ResMed is committed to reducing its environmental impact. Key climate commitments include:
- Near-Term Targets:
- Aims to reduce Scope 1 emissions to near zero by the middle of this decade (by 2025).
- Aims to reduce Scope 2 emissions to near zero by the middle of this decade (by 2025).
- Investigate electrification opportunities for Scope 1 and Scope 2 energy sources by 2025.
- Science Based Targets initiative (SBTi):
- Committed to reach net-zero greenhouse gas emissions across the value chain by FY2050, using FY2022 as a base year.
- Has set near-term targets to reduce absolute Scope 1 and 2 GHG emissions by 42% by FY2030 from a FY2022 base year.
- Also commits to reduce Scope 3 GHG emissions by 51.6% per MW constructed within the same near-term timeframe.
- Long-term targets include reducing Scope 1 and 2 GHG emissions by 90% by FY2050 from a FY2022 base year, and reducing Scope 3 GHG emissions by 97% per MW constructed within the same long-term timeframe.
ResMed is headquartered in the US and operates within the Medical, precision and optical instruments, watches and clocks industry (33).
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Resmed’s Climate Goals (2030 & 2050)
7 goals2050
90% reduction in Scope 1
RES commits to reduce Scope 1 GHG emissions 90% by FY2050 from a FY2022 base year.
2050
90% reduction in Scope 2
RES commits to reduce Scope 2 GHG emissions 90% by FY2050 from a FY2022 base year.
2030
42% reduction in Scope 1
RES commits to reduce absolute scope 1 GHG emissions 42% by FY2030 from a FY2022 base year.
See all 7 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Resmed
Frequently asked questions
Common questions about Resmed’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project